ID   SL9A7_HUMAN             Reviewed;         725 AA.
AC   Q96T83; O75827; Q5JXP9;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   07-APR-2021, entry version 150.
DE   RecName: Full=Sodium/hydrogen exchanger 7;
DE   AltName: Full=Na(+)/H(+) exchanger 7;
DE            Short=NHE-7;
DE   AltName: Full=Solute carrier family 9 member 7;
GN   Name=SLC9A7; Synonyms=NHE7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11279194; DOI=10.1074/jbc.m101319200;
RA   Numata M., Orlowski J.;
RT   "Molecular cloning and characterization of a novel (Na+,K+)/H+ exchanger
RT   localized to the trans-Golgi network.";
RL   J. Biol. Chem. 276:17387-17394(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SCAMP1; SCAMP2 AND SCAMP5.
RX   PubMed=15840657; DOI=10.1242/jcs.02315;
RA   Lin P.J., Williams W.P., Luu Y., Molday R.S., Orlowski J., Numata M.;
RT   "Secretory carrier membrane proteins interact and regulate trafficking of
RT   the organellar (Na+,K+)/H+ exchanger NHE7.";
RL   J. Cell Sci. 118:1885-1897(2005).
RN   [4]
RP   INVOLVEMENT IN MRX108, VARIANT MRX108 PHE-515, CHARACTERIZATION OF VARIANT
RP   MRX108 PHE-515, FUNCTION, GLYCOSYLATION AT ASN-145, SUBCELLULAR LOCATION,
RP   AND TOPOLOGY.
RX   PubMed=30335141; DOI=10.1093/hmg/ddy371;
RA   Khayat W., Hackett A., Shaw M., Ilie A., Dudding-Byth T., Kalscheuer V.M.,
RA   Christie L., Corbett M.A., Juusola J., Friend K.L., Kirmse B.M., Gecz J.,
RA   Field M., Orlowski J.;
RT   "A recurrent missense variant in SLC9A7 causes nonsyndromic X-linked
RT   intellectual disability with alteration of Golgi acidification and aberrant
RT   glycosylation.";
RL   Hum. Mol. Genet. 28:598-614(2019).
CC   -!- FUNCTION: Mediates electroneutral exchange of protons for Na(+) and
CC       K(+) across endomembranes. May contribute to the regulation of Golgi
CC       apparatus volume and pH. {ECO:0000269|PubMed:11279194,
CC       ECO:0000269|PubMed:30335141}.
CC   -!- SUBUNIT: Interacts with SCAMP1, SCAMP2 and SCAMP5; may participate in
CC       its shuttling from trans-Golgi network to recycling endosomes.
CC       {ECO:0000269|PubMed:15840657}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane
CC       {ECO:0000269|PubMed:15840657, ECO:0000269|PubMed:30335141}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:15840657}. Recycling endosome
CC       membrane {ECO:0000269|PubMed:15840657}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15840657}. Cell membrane
CC       {ECO:0000269|PubMed:30335141}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:11279194}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:30335141}.
CC   -!- DISEASE: Intellectual developmental disorder, X-linked 108 (MRX108)
CC       [MIM:301024]: A form of mental retardation, a disorder characterized by
CC       significantly below average general intellectual functioning associated
CC       with impairments in adaptive behavior and manifested during the
CC       developmental period. Intellectual deficiency is the only primary
CC       symptom of non-syndromic X-linked mental retardation, while syndromic
CC       mental retardation presents with associated physical, neurological
CC       and/or psychiatric manifestations. {ECO:0000269|PubMed:30335141}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- MISCELLANEOUS: Is not inhibited by amiloride but by benzamil and
CC       quinine.
CC   -!- SIMILARITY: Belongs to the monovalent cation:proton antiporter 1 (CPA1)
CC       transporter (TC 2.A.36) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF298591; AAK54508.1; -; mRNA.
DR   EMBL; AL050307; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL022165; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS14269.1; -.
DR   RefSeq; NP_115980.1; NM_032591.2.
DR   SMR; Q96T83; -.
DR   BioGRID; 124198; 4.
DR   IntAct; Q96T83; 3.
DR   MINT; Q96T83; -.
DR   STRING; 9606.ENSP00000480916; -.
DR   TCDB; 2.A.36.1.3; the monovalent cation:proton antiporter-1 (cpa1) family.
DR   GlyGen; Q96T83; 1 site.
DR   iPTMnet; Q96T83; -.
DR   PhosphoSitePlus; Q96T83; -.
DR   SwissPalm; Q96T83; -.
DR   BioMuta; SLC9A7; -.
DR   DMDM; 44888236; -.
DR   EPD; Q96T83; -.
DR   jPOST; Q96T83; -.
DR   MassIVE; Q96T83; -.
DR   MaxQB; Q96T83; -.
DR   PaxDb; Q96T83; -.
DR   PeptideAtlas; Q96T83; -.
DR   PRIDE; Q96T83; -.
DR   ProteomicsDB; 78214; -.
DR   TopDownProteomics; Q96T83; -.
DR   Antibodypedia; 25223; 118 antibodies.
DR   DNASU; 84679; -.
DR   Ensembl; ENST00000328306; ENSP00000330320; ENSG00000065923.
DR   GeneID; 84679; -.
DR   KEGG; hsa:84679; -.
DR   UCSC; uc004dgu.3; human.
DR   CTD; 84679; -.
DR   DisGeNET; 84679; -.
DR   GeneCards; SLC9A7; -.
DR   HGNC; HGNC:17123; SLC9A7.
DR   HPA; ENSG00000065923; Tissue enhanced (brain).
DR   MalaCards; SLC9A7; -.
DR   MIM; 300368; gene.
DR   MIM; 301024; phenotype.
DR   neXtProt; NX_Q96T83; -.
DR   OpenTargets; ENSG00000065923; -.
DR   Orphanet; 777; X-linked non-syndromic intellectual disability.
DR   PharmGKB; PA38200; -.
DR   VEuPathDB; HostDB:ENSG00000065923.9; -.
DR   eggNOG; KOG1965; Eukaryota.
DR   GeneTree; ENSGT00940000153460; -.
DR   InParanoid; Q96T83; -.
DR   PhylomeDB; Q96T83; -.
DR   TreeFam; TF318755; -.
DR   PathwayCommons; Q96T83; -.
DR   Reactome; R-HSA-425986; Sodium/Proton exchangers.
DR   BioGRID-ORCS; 84679; 6 hits in 617 CRISPR screens.
DR   ChiTaRS; SLC9A7; human.
DR   GenomeRNAi; 84679; -.
DR   Pharos; Q96T83; Tbio.
DR   PRO; PR:Q96T83; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q96T83; protein.
DR   Bgee; ENSG00000065923; Expressed in putamen and 207 other tissues.
DR   ExpressionAtlas; Q96T83; baseline and differential.
DR   Genevisible; Q96T83; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IBA:GO_Central.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0015386; F:potassium:proton antiporter activity; IDA:UniProtKB.
DR   GO; GO:0015385; F:sodium:proton antiporter activity; IDA:UniProtKB.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:1905526; P:regulation of Golgi lumen acidification; IMP:UniProtKB.
DR   GO; GO:0051453; P:regulation of intracellular pH; IBA:GO_Central.
DR   GO; GO:0006885; P:regulation of pH; IDA:UniProtKB.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; IBA:GO_Central.
DR   InterPro; IPR006153; Cation/H_exchanger.
DR   InterPro; IPR018422; Cation/H_exchanger_CPA1.
DR   InterPro; IPR004709; NaH_exchanger.
DR   InterPro; IPR002090; NHE6_7_9.
DR   PANTHER; PTHR10110; PTHR10110; 1.
DR   Pfam; PF00999; Na_H_Exchanger; 1.
DR   PRINTS; PR01084; NAHEXCHNGR.
DR   PRINTS; PR01088; NAHEXCHNGR6.
DR   TIGRFAMs; TIGR00840; b_cpa1; 1.
PE   1: Evidence at protein level;
KW   Antiport; Cell membrane; Disease variant; Endosome; Glycoprotein;
KW   Golgi apparatus; Ion transport; Membrane; Mental retardation;
KW   Phosphoprotein; Potassium; Potassium transport; Reference proteome; Sodium;
KW   Sodium transport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..725
FT                   /note="Sodium/hydrogen exchanger 7"
FT                   /id="PRO_0000052363"
FT   TOPO_DOM        1..21
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        22..42
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        43..70
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        71..91
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        92..95
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        96..116
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        117..175
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        176..196
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        197..210
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        211..231
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        232..251
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        252..272
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        273..277
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        278..298
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        299..322
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        323..343
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        344..349
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        350..370
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        371..391
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        392..414
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        415..435
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        436..442
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        443..463
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        464..474
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        475..497
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        498..513
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   TRANSMEM        514..534
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        535..725
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30335141"
FT   MOD_RES         545
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BLV3"
FT   CARBOHYD        145
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30335141"
FT   VARIANT         515
FT                   /note="L -> F (in MRX108; probable gain-of-function
FT                   variant; affects the regulation of trans-Golgi network/
FT                   post-Golgi pH homeostasis, causing alkalinization of these
FT                   compartments compared to wild-type, hence affecting its own
FT                   glycosylation and that of exported cargo proteins; no
FT                   effect on subcellular location in the Golgi apparatus and
FT                   plasma membrane)"
FT                   /evidence="ECO:0000269|PubMed:30335141"
FT                   /id="VAR_082101"
SQ   SEQUENCE   725 AA;  80131 MW;  14E50B197863E38F CRC64;
     MEPGDAARPG SGRATGAPPP RLLLLPLLLG WGLRVAAAAS ASSSGAAAED SSAMEELATE
     KEAEESHRQD SVSLLTFILL LTLTILTIWL FKHRRVRFLH ETGLAMIYGL IVGVILRYGT
     PATSGRDKSL SCTQEDRAFS TLLVNVSGKF FEYTLKGEIS PGKINSVEQN DMLRKVTFDP
     EVFFNILLPP IIFHAGYSLK KRHFFRNLGS ILAYAFLGTA VSCFIIGNLM YGVVKLMKIM
     GQLSDKFYYT DCLFFGAIIS ATDPVTVLAI FNELHADVDL YALLFGESVL NDAVAIVLSS
     SIVAYQPAGL NTHAFDAAAF FKSVGIFLGI FSGSFTMGAV TGVNANVTKF TKLHCFPLLE
     TALFFLMSWS TFLLAEACGF TGVVAVLFCG ITQAHYTYNN LSVESRSRTK QLFEVLHFLA
     ENFIFSYMGL ALFTFQKHVF SPIFIIGAFV AIFLGRAAHI YPLSFFLNLG RRHKIGWNFQ
     HMMMFSGLRG AMAFALAIRD TASYARQMMF TTTLLIVFFT VWIIGGGTTP MLSWLNIRVG
     VEEPSEEDQN EHHWQYFRVG VDPDQDPPPN NDSFQVLQGD GPDSARGNRT KQESAWIFRL
     WYSFDHNYLK PILTHSGPPL TTTLPAWCGL LARCLTSPQV YDNQEPLREE DSDFILTEGD
     LTLTYGDSTV TANGSSSSHT ASTSLEGSRR TKSSSEEVLE RDLGMGDQKV SSRGTRLVFP
     LEDNA
//
